AI Bias Analysis
4 models · Takes ~15 seconds
Otsuka’s Voyxact slowed the loss of kidney function after one year in patients with a chronic autoimmune kidney disease, but the benefit was less than expected.
Source
Stat News
Opens original article in a new tab
Americans who have high-risk exposures to Ebola in the current outbreak in Central Africa will have access to an experimental antibody treatment.
(MedPage Today) -- A major change to how the popular President's Emergency Plan for AIDS Relief (PEPFAR) program operates took effect on June 1, which experts warn will result in a massive decline in the U.S.'s public health presence abroad. Historically...
(MedPage Today) -- People who consumed the most ultraprocessed foods -- sugar-sweetened drinks, packaged snacks, or processed meats, for example -- were more likely to develop a composite outcome of dementia or cognitive impairment compared...
(MedPage Today) -- Amarin Pharma has not done enough to definitively show that its generic competitor, Hikma Pharmaceuticals, is infringing on Amarin's patents for its anti-hypertriglyceridemia drug icosapent ethyl (Vascepa), the Supreme Court...
